BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 17059971)

  • 1. Economics of diabetes mellitus.
    Krein SL; Funnell MM; Piette JD
    Nurs Clin North Am; 2006 Dec; 41(4):499-511, v-vi. PubMed ID: 17059971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care.
    Piette JD; Wagner TH; Potter MB; Schillinger D
    Med Care; 2004 Feb; 42(2):102-9. PubMed ID: 14734946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluations and diabetes.
    Pathak DS; Burke TA
    Pharm Pract Manag Q; 1998 Jan; 17(4):17-24. PubMed ID: 10174745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes.
    Hoerger TJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S21-7. PubMed ID: 19536014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of diabetes in Latin America and the Caribbean.
    Barceló A; Aedo C; Rajpathak S; Robles S
    Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetime health effects and costs of diabetes treatment.
    Niessen LW; Dijkstra R; Hutubessy R; Rutten GE; Casparie AF
    Neth J Med; 2003 Nov; 61(11):355-64. PubMed ID: 14768718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health economics analysis of diabetes is necessary. It facilitates decision-making and international comparison].
    Henriksson F; Agardh CD; Berne C; Bolinder J; Jönsson B
    Lakartidningen; 1999 Sep; 96(37):3915-6, 3919. PubMed ID: 10522101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of treating type 2 diabetes (CODEIRE).
    Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
    Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of ambulatory care of diabetes mellitus: a study from north India.
    Grover S; Avasthi A; Bhansali A; Chakrabarti S; Kulhara P
    Postgrad Med J; 2005 Jun; 81(956):391-5. PubMed ID: 15937206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy.
    Berger J
    Am J Manag Care; 2007 Apr; 13 Suppl 2():S55-8. PubMed ID: 17417934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
    Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
    Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design.
    Sullivan MD; Anderson RT; Aron D; Atkinson HH; Bastien A; Chen GJ; Feeney P; Gafni A; Hwang W; Katz LA; Narayan KM; Nwachuku C; O'Connor PJ; Zhang P;
    Am J Cardiol; 2007 Jun; 99(12A):90i-102i. PubMed ID: 17599429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics.
    Levin P
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():66-75. PubMed ID: 18577158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study.
    Tseng CW; Tierney EF; Gerzoff RB; Dudley RA; Waitzfelder B; Ackermann RT; Karter AJ; Piette J; Crosson JC; Ngo-Metzger Q; Chung R; Mangione CM
    Diabetes Care; 2008 Feb; 31(2):261-6. PubMed ID: 18000177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economics in pediatric type 1 diabetes - results from recently published studies.
    Icks A; Holl RW; Giani G
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):448-54. PubMed ID: 17647143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An economic review of the management of diabetes mellitus].
    Tsujii S
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():623-30. PubMed ID: 12430293
    [No Abstract]   [Full Text] [Related]  

  • 19. The economic analyses of the UK prospective diabetes study.
    Gray AM; Clarke P
    Diabet Med; 2008 Aug; 25 Suppl 2():47-51. PubMed ID: 18717979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
    Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
    Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.